Did any named executive officers exercise
options or have other stock awards vest in 2022?
All our named executive officers had outstanding awards of restricted stock units vest in
2022. No restricted stock or stock options vested in 2022. No options were exercised in 2022.
OPTION EXERCISES AND STOCK VESTED IN 2022(1)
|
Robert J. Sprowls
|
|
|
20,666(3)
|
|
|
$1,100,785
|
|
|
Eva G. Tang
|
|
|
3,178(4)
|
|
|
133,459
|
|
|
Paul J. Rowley
|
|
|
1,109
|
|
|
98,240
|
|
|
Christopher H. Connor
|
|
|
—
|
|
|
—
|
|
|
Gladys M. Farrow
|
|
|
2,401(5)
|
|
|
103,399
|
|
(1) We determined the value realized on vesting of restricted
stock units based on the closing market price of our common shares on the date of vesting as reported on The Wall Street Journal website (www.wsj.com).
(2) Includes performance stock award granted in 2020 which vested in 2022.
(3) Out of 20,666 shares fully vested in 2022, Mr. Sprowls
acquired 4,098 common shares on February 4, 2022, upon the payout of restricted stock units with a market value of $367,520 on the date of acquisition. Mr. Sprowls is entitled to acquire the remaining 16,568 common shares, which were not
payable during 2022, because of the immediate vesting of these common shares under the Rule of 75. Mr. Sprowls acquired 3,988 of these common shares on February 10, 2023 with a market value of $369,091 on the date of acquisition. On March 15,
2023, Mr. Sprowls acquired 8,455 of these common shares (including 38 common shares with respect to dividends declared on February 7, 2023 pursuant to dividend equivalent rights on these shares) with an aggregate market value of $733,265 on the
date of acquisition. Mr. Sprowls was entitled to acquire the remaining 4,125 common shares, which were not payable during 2022, because of the vesting of these common shares under the Rule of 75. Mr. Sprowls has the right to acquire 1,295 of
these common shares within 30 days from January 30, 2024, 1,496 of these common shares within 30 days from January 31, 2024 and 1,334 of these common shares within 30 days from January 30, 2025 as a result of the previous vesting of the 4,125
restricted stock units, the value of which was not realized during 2022, plus common shares with respect to dividends declared after December 31, 2022 on these common shares pursuant to dividend equivalent rights on these shares until the date
of acquisition of these shares.
(4) Out of 3,178 shares fully vested in 2022, Ms. Tang acquired
920 common shares on February 4, 2022, upon the payout of restricted stock units with a market value of $82,491 on the date of acquisition. Ms. Tang is entitled to acquire the remaining 2,258 common shares, which were not payable during 2022,
because of the immediate vesting of these common shares under the Rule of 75. Ms. Tang acquired 841 of these common shares on February 10, 2023 with a market value of $77,847 on the date of acquisition. On March 15, 2023, Ms. Tang acquired 588
of these common shares (including 3 common shares with respect to dividends declared on February 7, 2023 pursuant to dividend equivalent rights on these shares) with an aggregate market value of $50,968 on the date of acquisition. Ms. Tang was
entitled to acquire the remaining 829 common shares, which were not payable during 2022, because of the vesting of these common shares under the Rule of 75. Ms. Tang has the right to acquire 228 of these common shares within 30 days from
January 30, 2024, 366 of these common shares within 30 days from January 31, 2024 and 235 of these common shares within 30 days from January 30, 2025 as a result of the previous vesting of the 829 restricted stock units, the value of which was
not realized during 2022, plus common shares with respect to dividends declared after December 31, 2022 on these common shares pursuant to dividend equivalent rights on these shares until the date of acquisition of these shares.
(5) Out of 2,401 shares fully vested in 2022, Ms. Farrow
acquired 674 common shares on February 4, 2022, upon the payout of restricted stock units with a market value of $60,476 on the date of acquisition. Ms. Farrow acquired 75 common shares on March 14, 2022, upon the payout of restricted stock
units with a market value of $6,255 on the date of acquisition. Ms. Farrow is entitled to acquire the remaining 1,652 common shares, which were not payable during 2022, because of the immediate vesting of these common shares under the Rule of
75. Ms. Farrow acquired 619 of these common shares on February 10, 2023 with a market value of $57,290 on the date of acquisition. On March 14, 2023, Ms. Farrow acquired 423 of these common shares (including 2 common shares with respect to
dividends declared on February 7, 2023 pursuant to dividend equivalent rights on these shares) with an aggregate market value of $36,668 on the date of acquisition. Ms. Farrow was entitled to acquire the remaining 610 common shares, which were
not payable during 2022, because of the vesting of these common shares under the Rule of 75. Ms. Farrow has the right to acquire 164 of these common shares within 30 days from January 30, 2024, 277 of these common shares within 30 days from
January 31, 2024 and 169 of these common shares within 30 days from January 30, 2025 as a result of the previous vesting of the 610 restricted stock units, the value of which was not realized during 2022, plus common shares with respect to
dividends declared after December 31, 2022 on these common shares pursuant to dividend equivalent rights on these shares until the date of acquisition of these shares.